The effect of yoga on endocrine therapy induced musculoskeletal symptoms in women with breast cancer - COBRA study

niversitair Medisch Centrum Utrecht0 sites140 target enrollmentTBD

Overview

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

last year

Study Type

Interventional

Sponsor

niversitair Medisch Centrum Utrecht

•To be eligible to participate in this study, a woman must:
•o Be diagnosed with oestrogen\-receptor positive stage I\-III breast cancer,
•o Use of aromatase inhibitors (\>4 months and will continue using it for at
•least six months),
•o Have finished primary treatment (chemotherapy, radiotherapy, surgery) for at
•least six weeks,
•o Experience musculoskeletal complaints (\>3 months, which are at least mild in
•severity (i.e., score of \>\= 3 for worst pain item of a modified version of the
•Brief Pain Inventory \[BPI], which started or exacerbated after initiation of
•endocrine treatment,

•A woman who meets any of the following criteria will be excluded from
•participation in this study:
•\- Too physically active (i.e., \>150 minutes/week of self\-reported
•moderate\-to\-vigorous or leisure and sports activities)
•\- Following (during the last 6 months), or planned to follow yoga classes on a
•structural base
•\- Following, or planned to follow, a structured psychological intervention
•during the intervention period, i.e., cognitive behavioral therapy, or unstable
•on psychotropic medication
•\- Participated in the intervention group of an exercise study during breast